| Financial Year |
March 31 2023 |
| Monetary Funds |
1,025,728,871.52 |
| Held-for-trading Financial Assets |
225,000,000.00 |
| Notes Receivable |
230,966,528.89 |
| Accounts Receivable |
639,834,932.10 |
| Advances to Suppliers |
15,374,105.17 |
| Other Receivables |
82,715,043.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
140,071,086.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,337,530.85 |
| Total Current Assets |
2,582,171,320.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
683,517,580.14 |
| Under-construction Projects |
141,328,865.25 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
117,795,577.90 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,785,103.19 |
| Deferred Income Tax Assets |
1,724,245.86 |
| Other Non-Current Assets |
80,566,916.18 |
| Sub-Total of Non-Current Assets |
1,027,714,002.76 |
| Total Assets |
3,609,885,322.90 |
| Short-Term Loans |
150,738,709.76 |
| Trading Financial liabilities |
-- |
| Notes Payable |
627,287,391.09 |
| Accounts Payable |
154,901,287.97 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
21,430,404.00 |
| Taxes Payable |
5,541,427.21 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
17,490,703.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
751,342.04 |
| Other Current Liabilities |
67,487,702.42 |
| Sub-Total of Current Liabilities |
1,052,518,448.79 |
| Long-term Loans |
75,417,847.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
83,481,458.31 |
| Total Liabilities |
1,135,999,907.10 |
| Paid-In Capital(Or Share Stock) |
903,875,195.00 |
| Capital Surplus |
340,480,980.02 |
| Surplus Reserve |
128,680,972.85 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,101,604,528.27 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,473,885,415.80 |
| Owner's Equity（Stockholder's Equity） |
2,473,885,415.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,609,885,322.90 |
